RxDoctor Payments Data

Joseph Kim, MD

Surgery · Lexington, KYNPI 1295804052

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (45.4%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Genentech USA, Inc. at 30.7% of the total. Reporting peaked in 2020 at $18,484 and has fallen 76.5% since, to $4,345 in 2025. Among surgery clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$46,742in general payments, 2019–2025

Across 84 payments — averaging $556.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech USA, Inc.$14K
  • Sirtex Medical Inc$13K
  • Merck$10K
  • Intuitive Surgical$4K
  • Elucent Medical$1K
  • Ipsen Biopharmaceuticals, Inc$690
  • plus $3K from 12 others
$1,551,628in research payments, 2019–2025

Across 29 payments — averaging $53,504 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$1M
  • Exelixis Inc.$368K
  • Genentech, Inc.$172K

What the payments were for

  • Consulting fees$10,05022%
  • Speaking & faculty fees$21,23045%
  • Travel & lodging$7,06715%
  • Food & beverage$5,39512%
  • Education$3,0006%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Genentech USA, Inc.20$14,328
Sirtex Medical Inc11$12,908
Merck1$10,000
Intuitive Surgical7$4,327
Elucent Medical2$1,224
Ipsen Biopharmaceuticals, Inc7$690
Tempus AI, Inc5$583
Medtronic8$570
Angiodynamics, Inc.9$541
Intera Oncology, Inc3$297
Exelixis Inc.2$271
BK Medical Holding Company Inc.1$190
Davol Inc.2$184
GE HealthCare1$147
Genentech, Inc.1$137
Puma Biotechnology, Inc.2$130
Novartis1$130
Epizyme, Inc.1$86

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$46,742 in reported general payments places this provider in the 95th percentile of 377 surgery providers in Kentucky.

See all surgery providers in Kentucky

Medicare billing

Part B allowed, 2024
$106,599
Medicare patients
91
Services billed
277

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase17$37,405

Paid to pharmacies, not to this prescriber.

Other surgery in Lexington

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →